Advertisements



Guggenheim says Seattle Genetics" cervical cancer data "a positive surprise"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 30th, 2020

Seattle Genetics, Astellas Report Positive Cancer Study Data

Seattle Genetics (SGEN) and partner Astellas present positive top-line data from the first cohort of a phase II study on enfortumab vedotin for treating patients with advan.....»»

Category: dealsSource: nytMar 29th, 2019

Seattle Genetics, Astellas Report Positive Cancer Study Data

Zacks.....»»

Category: topSource: redinewsMar 29th, 2019

Seattle Genetics" stock rises on early FDA nod for breast-cancer drug

Shares of Seattle Genetics Inc. gained 1.0% in trading on Friday after the Food and Drug Administration approved Tukysa for certain patients with HER2-positive breast cancer when given in combination with chemotherapy. The drug has a wholesale.....»»

Category: topSource: marketwatchApr 17th, 2020

Seattle Genetics, Astellas advance after updated data for bladder cancer study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2020

Seattle Genetics data positive but inline with expectations, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 11th, 2019

Big Step Forward in HER2-Positive Breast Cancer Trial

Seattle Genetics shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial......»»

Category: blogSource: 247wallstOct 21st, 2019

Seattle Genetics stock up 14% on news of positive trial of breast cancer treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 21st, 2019

Seattle Genetics Rallies To Record High On Positive Results From Midstage Breast Cancer Study

Shares of the large-cap biopharma Seattle Genetics, Inc. (NASDAQ: SGEN) were advancing strongly Monday following a clinical trial readout from the company. read more.....»»

Category: blogSource: benzingaOct 21st, 2019

Seattle Genetics stock soars 15% on positive trial of breast cancer treatment

Seattle Genetics Inc. shares soared 15% Monday, aft.....»»

Category: topSource: marketwatchOct 21st, 2019

Seattle Genetics, Astellas" Cancer Candidate Attains 44% ORR

Seattle Genetics (SGEN) and Astellas post favorable data from the first cohort of a phase II study on enfortumab vedotin for treating advanced/metastatic urothelial cancer. Shares up as the candidate.....»»

Category: dealsSource: nytJun 4th, 2019

Seattle Genetics positive data already priced into shares, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2018

Shares of Immunomedics jump on positive confirmatory data for its breast-cancer drug

Shares of Immunomedics Inc. gained 6.9% in trading on Monday after the drugmaker said a confirmatory Phase 3 clinical trial of its breast-cancer drug Trodelvy met its primary and secondary endpoints. The Food and Drug Admini.....»»

Category: topSource: marketwatchJul 6th, 2020

Seattle Genetics reports "positive" results from Phase 2 tisotumab vedotin trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 29th, 2020

Guggenheim upgrades Eli Lilly to Buy after "transformational" breast cancer data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 16th, 2020

Guggenheim upgrades Seattle Genetics to Buy on 40% sales growth potential

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 1st, 2020

Seattle Genetics upgraded to Buy from Neutral at Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 1st, 2020

Seattle Genetics" Tukysa approved by FDA for certain breast cancer patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 17th, 2020

Stifel says Seattle Genetics FDA talks on EV positive, but not surprising

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 3rd, 2020

How CTI BioPharma will use its $60M rights offering

The Seattle biotech, which was out of compliance with Nasdaq in December, has regained its standing due to positive data shared at a conference Dec. 9......»»

Category: topSource: bizjournalsFeb 21st, 2020

GlaxoSmithKline CEO expects to get "at least" six drug approvals from the FDA in 2020

GlaxoSmithKline CEO Emma Walmsley told "Mad Money" host Jim Cramer the British drugmaker has received "positive data" for cancer and HIV drugs......»»

Category: topSource: madmoneyJan 13th, 2020